Arun Azad
Onco
Daily
Twitter
Facebook
Youtube
RSS Feed
Linkedin
Facebook
RSS
Twitter
Youtube
Linkedin
May, 2024
May 2024
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
« Apr
Arun Azad
Apr 21, 2024, 10:09 |
Blog
Arun Azad: Pleased to share our latest work published in Urologic Oncology focusing on precision medicine in prostate cancer
Arun Azad, Consultant Medical Oncologist at Peter MacCallum Cancer Centre, shared on X/Twitter: ''Pleased to…
Jun 24, 2023, 18:25 |
Drugs
Still no role for targeting PI3K pathway in mCRPC - Arun Azad
Now online Clinical Cancer Research- Phase IB study ipatasertib plus ipatasertib in mCR prostate cancer…
Jun 21, 2023, 18:41 |
Drugs
So pleased (& a little proud) to see U.S. FDA approval of Enzalutamide & Talazoparib in HRR-deficient 1L mCRPC
In a post by Arun Azad on Twitter, it says, "So pleased (& a little…
All:
3
Posts:
1 - 10
10 Most Promising Cancer Drugs Not Yet Approved: Solid Tumors - 2024 edition by OncoDaily
Elie G. Dib: Excited to share the results of the TAPUR study
OncoInfluencers: Dialogue with Fadlo R. Khuri, hosted by Gevorg Tamamyan
Cedars-Sinai is co-chairing a special AACR conference on transforming the field of Bladder Cancer on May 17-20
Barbara Jereczek-Fossa has been elected as the ESTRO President-elect!
Facebook
RSS Feed
Twitter
Linkedin
Youtube